Naviscan Inc.
SAN DIEGO, September 8, 2011 -
Positron Emission Mammography (PEM) Expands into 13 European Countries
Naviscan, the leader in organ-specific molecular imaging, announced today that it obtained CE Mark approval for both its high-resolution PET scanner and PET-guided biopsy accessory.
SAN DIEGO, May 3, 2011 - Naviscan, Inc., the leader in 3D Molecular Breast Imaging (MBI), has
entered into a distribution agreement with Tecnologie Avanzate s.r.l.
SAN DIEGO, March 31, 2011 - The Breast Journal recently published original prospective data
confirming the technical validity of image-guided needle biopsy of suspicious
breast cancer lesions using Positron Emission Mammography (PEM)-guidance.
VIENNA, March 2, 2011 - Naviscan, Inc., announces the European launch of the Naviscan Positron
Emission Mammography (PEM) scanner at two prestigious radiology conferences
in Vienna.
